Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Risk and Reward: Pharmacy Compounding of Clinical Materials

This article was originally published in The Gold Sheet

Executive Summary

More and more, drug makers are using pharmacies to compound their clinical materials quicker and cheaper than they themselves could manufacture them – but at what cost? The New England Compounding Center disaster and other incidents over the years make it clear that they must provide careful oversight to ensure quality.

You may also be interested in...



Manufacturers, Compounders Clash As FDA Prepares Final Offer On Office Compounding

Pharmaceutical manufacturers and compounders are in opposition over the US FDA’s plans to carve out a place for pharmacies that want to keep physicians’ offices stocked with small amounts of product. Who will the agency disappoint this time?

NECC Crisis Festered in Ambiguity That Reigns Over Compounding

As FDA, Congress and the courts stumbled, compounding pharmacies such as NECC took advantage of a gray area of the law. Legislators will get another try; one proposed subjecting such pharmacies to cGMP requirements.

A Lesson on Outsourcing: The NECC Fungal Meningitis Outbreak

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

PS000818

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel